Ciulla Thomas 4
4 · Viridian Therapeutics, Inc.\DE · Filed Feb 7, 2024
Insider Transaction Report
Form 4
Ciulla Thomas
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-02-05+50,000→ 50,000 totalExercise: $18.70Exp: 2034-02-05→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests in 48 equal monthly installments, subject to the Reporting Person's continued service to Issuer through each vesting date.